Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641172-25-024386
Filing Date
2025-08-15
Accepted
2025-08-15 16:30:24
Documents
3
Period of Report
2025-08-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm DEF 14A 163065
2 GRAPHIC formdef14a_001.jpg GRAPHIC 1249407
3 GRAPHIC formdef14a_002.jpg GRAPHIC 1402422
  Complete submission text file 0001641172-25-024386.txt   3813968
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

EIN.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40874 | Film No.: 251225103
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)